Search research articles
Contact Us
Filters
Showing results (531-540 of 589) with videos related to
Page
of 59
Sort By:
Journal of Cosmetic Dermatology
|
November 24, 2012
SIG1273: a new cosmetic functional ingredient to reduce blemishes and Propionibacterium acnes in acne prone skin
José R Fernandéz, Karl Rouzard, Michael Voronkov, et al.
Molecular Cell
|
August 23, 2011
Interaction profiling identifies the human nuclear exosome targeting complex
Michal Lubas, Marianne S Christensen, Maiken S Kristiansen, et al.
Journal of Clinical Microbiology
|
December 2, 2000
Results of multiple diagnostic tests for Mycobacterium avium subsp. paratuberculosis in patients with inflammatory bowel disease and in controls
M T Collins, G Lisby, C Moser, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
August 26, 2022
Trends and drivers of pharmaceutical expenditures from systemic anti-cancer therapy
Lars Børty, Rasmus F Brøndum, Heidi S Christensen, et al.
British Journal of Cancer
|
April 22, 2015
A randomised phase II trial of selumetinib vs selumetinib plus temsirolimus for soft-tissue sarcomas
Z Eroglu, H A Tawbi, J Hu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 23, 2011
Phase I study of continuous and intermittent schedules of lapatinib in combination with vinorelbine in solid tumors
H K Chew, G Somlo, P C Mack, et al.
Scandinavian Journal of Gastroenterology
|
October 9, 2003
Pharmacological monitoring of azathioprine therapy
L O Reuther, J Sonne, N E Larsen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 10, 1998
SB 207499 (Ariflo), a second generation phosphodiesterase 4 inhibitor, reduces tumor necrosis factor alpha and interleukin-4 production in vivo
D E Griswold, E F Webb, A M Badger, et al.
European Journal of Biochemistry
|
February 17, 2001
A novel carbohydrate:acceptor oxidoreductase from Microdochium nivale
F Xu, E J Golightly, C C Fuglsang, et al.
Cerebrovascular Diseases (Basel, Switzerland)
|
November 7, 2009
Baseline diabetic status and admission blood glucose were poor prognostic factors in the EPITHET trial
D A De Silva, M Ebinger, S Christensen, et al.
Page
of 59
Search research articles
Search
Showing results (531-540 of 589) with videos related to
Sort By:
Page
of 59
Journal of Cosmetic Dermatology
|
November 24, 2012
SIG1273: a new cosmetic functional ingredient to reduce blemishes and Propionibacterium acnes in acne prone skin
José R Fernandéz, Karl Rouzard, Michael Voronkov, et al.
Molecular Cell
|
August 23, 2011
Interaction profiling identifies the human nuclear exosome targeting complex
Michal Lubas, Marianne S Christensen, Maiken S Kristiansen, et al.
Journal of Clinical Microbiology
|
December 2, 2000
Results of multiple diagnostic tests for Mycobacterium avium subsp. paratuberculosis in patients with inflammatory bowel disease and in controls
M T Collins, G Lisby, C Moser, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
August 26, 2022
Trends and drivers of pharmaceutical expenditures from systemic anti-cancer therapy
Lars Børty, Rasmus F Brøndum, Heidi S Christensen, et al.
British Journal of Cancer
|
April 22, 2015
A randomised phase II trial of selumetinib vs selumetinib plus temsirolimus for soft-tissue sarcomas
Z Eroglu, H A Tawbi, J Hu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 23, 2011
Phase I study of continuous and intermittent schedules of lapatinib in combination with vinorelbine in solid tumors
H K Chew, G Somlo, P C Mack, et al.
Scandinavian Journal of Gastroenterology
|
October 9, 2003
Pharmacological monitoring of azathioprine therapy
L O Reuther, J Sonne, N E Larsen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 10, 1998
SB 207499 (Ariflo), a second generation phosphodiesterase 4 inhibitor, reduces tumor necrosis factor alpha and interleukin-4 production in vivo
D E Griswold, E F Webb, A M Badger, et al.
European Journal of Biochemistry
|
February 17, 2001
A novel carbohydrate:acceptor oxidoreductase from Microdochium nivale
F Xu, E J Golightly, C C Fuglsang, et al.
Cerebrovascular Diseases (Basel, Switzerland)
|
November 7, 2009
Baseline diabetic status and admission blood glucose were poor prognostic factors in the EPITHET trial
D A De Silva, M Ebinger, S Christensen, et al.
Page
of 59